11-108250699-A-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_000051.4(ATM):c.1236-2A>T variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000051.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.1236-2A>T | splice_acceptor_variant, intron_variant | Intron 9 of 62 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 15AN: 85722Hom.: 0 Cov.: 26 FAILED QC
GnomAD3 exomes AF: 0.0000770 AC: 13AN: 168756Hom.: 0 AF XY: 0.0000535 AC XY: 5AN XY: 93480
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000431 AC: 55AN: 1277532Hom.: 0 Cov.: 36 AF XY: 0.0000425 AC XY: 27AN XY: 635658
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000175 AC: 15AN: 85770Hom.: 0 Cov.: 26 AF XY: 0.000147 AC XY: 6AN XY: 40856
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:2
This sequence change affects an acceptor splice site in intron 9 of the ATM gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. Disruption of this splice site has been observed in individual(s) with breast cancer and ataxia-telangiectasia (PMID: 14695534, 24763289, 30303537). ClinVar contains an entry for this variant (Variation ID: 375249). Studies have shown that disruption of this splice site alters ATM gene expression (PMID: 14695534). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
- -
Malignant tumor of urinary bladder Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1236-2A>T intronic pathogenic mutation results from an A to T substitution two nucleotides upstream from coding exon 9 in the ATM gene. This nucleotide position is highly conserved in available vertebrate species. This alteration was identified in 1/1207 cases of French women diagnosed with breast cancer who had a sister with breast cancer and were BRCA1 and BRCA2 negative and 1/1199 general population controls (Girard E et al. Int J Cancer, 2019 04;144:1962-1974). In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and will result in the creation or strengthening of a novel splice acceptor site. RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). Another alteration impacting the same acceptor site (c.1236-2A>G) has been identified in multiple individuals with ataxia telangiectasia (A-T) and has been shown to have a similar impact on splicing (Coutinho G et al. Am J Med Genet A, 2004 Apr;126A:33-40). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Familial cancer of breast Pathogenic:1
This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at